Model Number 310C |
Device Problems
Structural Problem (2506); Torn Material (3024)
|
Patient Problem
Mitral Regurgitation (1964)
|
Event Date 02/03/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
Without the return of the product, no definitive conclusion can be made regarding the clinical observation.(b)(4).
|
|
Event Description
|
Medtronic received information that eleven months following implant of this bioprosthetic mitral valve, this valve was explanted and replaced due to moderate regurgitation resulting from a leaflet tear.No adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: upon receipt at medtronic¿s quality laboratory, the returned product specimen was visually examined.All leaflets appeared intact and were found to be slightly stiff but flexible.The flat appearance on the top of the non-coronary commissure and bias cloth showed possible signs of pannus overgrowth which leaves the non-coronary cusp in the open position possibly resulting with restricted leaflet movement.A portion of the free margin of the non-coronary cusp appeared to fold back on itself, resting against the inner outflow rail.There was no evidence of a tear or damage on the leaflets.All commissures appeared to be intact.Remnants of pannus remained attached to the sewing ring on the inflow and outflow with traces on all stent posts.An unknown amount of pannus appears to have been removed on the inflow and outflow during explant.Radiography testing showed no evidence of mineralization in the valve and/or host tissue.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Based on the received information and the returned product analysis, the root cause to the reported regurgitation can be most likely attributed to the leaflet not coapting properly, secondary to the observed pannus overgrowth.Pannus overgrowth is associated with surgical valve replacement due to patient interaction and/or healing response with the surgical valve.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|